CoreAge Rx vs Tell Her Doc
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Tell Her Doc head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 67 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Tell Her Doc a bad call — it's best for readers seeking several treatment formats who can confirm the selected prescription, clinical practice and upfront subscription charge. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Tell Her Doc |
|---|---|---|
| Brief Score | 94/100 (A) | 67/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm the full selected plan Compounded semaglutide offered; generic $269 start does not establish the drug, supplied period or full payment. Introductory oral offers, injections and branded alternatives have separate conditions. Full price detailsCompounded semaglutide offered; current complete selected-plan quote unknown; generic GLP-1 starting figure $269 lacks a clear drug/period mapping; earlier listing: From $269/mo (microdose tier, plus a separate fee, compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm the full selected plan Compounded tirzepatide offered; generic $269 start is not a confirmed separate tirzepatide quote. Request medication, supplied weeks, upfront total and renewal terms. Full price detailsCompounded tirzepatide offered; current complete selected-plan quote unknown; generic GLP-1 starting figure $269 does not establish a separate tirzepatide total; earlier listing: Not disclosed |
| Coverage | US only; restrictions by state, confirmed at intake | Homepage advertises all fifty states; confirm the selected clinician, treatment and pharmacy are available for your physical location |
| Brand-name access | Not confirmed | Homepage lists Ozempic and Zepbound as limited-stock alternatives; confirm current availability and their separate medication and care quotes. |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Tell Her Doc: Generic GLP-1 start is $269; the page does not establish a full drug-specific period/renewal quote. Oral introduction and branded alternatives require separate terms.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.